Race and gender variation in response to evoked inflammation

Jane F. Ferguson, Parth N. Patel, Rhia Y. Shah, Claire K. Mulvey, Ram Gadi, Prabhjot S. Nijjar, Haris M. Usman, Nehal N. Mehta, Rachana Shah, Stephen R. Master, Kathleen J. Propert, Muredach P. Reilly

Research output: Contribution to journalArticlepeer-review

62 Scopus citations


Background: Race- and gender-variation in innate immunity may contribute to demographic differences in inflammatory and cardiometabolic disease; yet their influence on dynamic responses during inflammatory stress is poorly understood. Our objective was to examine race and gender influence on the response to experimental endotoxemia.Methods: The Genetics of Evoked Responses to Niacin and Endotoxemia (GENE) study was designed to investigate regulation of inflammatory and metabolic responses during low-grade endotoxemia (LPS 1 ng/kg intravenously) in healthy individuals (median age 24, IQR=7) of European (EA; n=193, 47% female) and African ancestry (AA; n=101, 59% female).Results: Baseline clinical, metabolic, and inflammatory biomarkers by race and gender were consistent with epidemiological literature; pre-LPS cytokines (e.g. median (IQR) IL-6, 2.7 (2) vs.2.1 (2) pg/ml, P=0.001) were higher in AA than EA. In contrast, acute cytokine responses during endotoxemia were lower in AA than EA (e.g. median (IQR) peak IL-1RA, 30 (38) vs.43 (45) ng/ml P=0.002) as was the induction of hepatic acute-phase proteins (e.g. median (IQR) peak CRP 12.9 (9) vs.17.4 (12) mg/L P=0.005). Further, baseline levels of cytokines were only weakly correlated with peak inflammatory responses (all rs <0.2) both in AA and in EA. There were less pronounced and less consistent differences in the response by gender, with males having a higher AUC for CRP response compared to females (median (IQR) AUC: 185 (112) vs. 155 (118), P=0.02).Conclusions: We observed lower levels of evoked inflammation in response to endotoxin in AA compared with EA, despite similar or higher baseline levels of inflammatory markers in AA. Our data also suggest that levels of inflammatory biomarkers measured in epidemiological settings might not predict the degree of acute stress-response or risk of diseases characterized by activation of innate immunity.Trial registration: FDA clinicaltrials.gov registration number NCT00953667.

Original languageEnglish (US)
Article number63
JournalJournal of Translational Medicine
Issue number1
StatePublished - Mar 12 2013

Bibliographical note

Funding Information:
The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR000003 as well as a NIH-NHLBI SCCOR Project grant (P50-HL-083799) to MPR. JFF is supported by a postdoctoral fellowship grant from the American Heart Association (12POST11840017). MPR is also supported by RO1-HL-111694, RO1-HL-113147, RO1-DK-090505, UO1-HL-108636 and K24-HL-107643. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.


Dive into the research topics of 'Race and gender variation in response to evoked inflammation'. Together they form a unique fingerprint.

Cite this